Elanco Animal Health (ELAN) Liabilities and Shareholders Equity (2017 - 2026)

Elanco Animal Health has disclosed Liabilities and Shareholders Equity across 10 years of filings, most recently posting $13.2 billion for Q1 2026.

• Liabilities and Shareholders Equity for Q1 2026 came in at $13.2 billion, up 2.17% year-over-year; the trailing twelve-month figure through Mar 2026 was $53.9 billion (up 2.42% YoY), and the FY2025 annual result was $13.4 billion, up 5.9% from the prior year.
• Liabilities and Shareholders Equity came in at $13.2 billion for Q1 2026 at Elanco Animal Health, down from $13.4 billion in the prior quarter.
• In the past five years, Liabilities and Shareholders Equity ranged from a high of $16.3 billion in Q1 2022 to a low of $12.6 billion in Q4 2024.
• The 5-year median for Liabilities and Shareholders Equity is $14.0 billion (2024), against an average of $14.3 billion.
• Across the five-year window, Liabilities and Shareholders Equity declined 12.86% in 2024 and advanced 5.9% in 2025, its largest moves.
• Elanco Animal Health's Liabilities and Shareholders Equity stood at $15.5 billion in 2022, then decreased by 7.29% to $14.4 billion in 2023, then declined by 12.17% to $12.6 billion in 2024, then gained by 5.9% to $13.4 billion in 2025, then dropped by 1.02% to $13.2 billion in 2026.
• The last three Liabilities and Shareholders Equity figures came in at $13.2 billion (Q1 2026), $13.4 billion (Q4 2025), and $13.6 billion (Q3 2025), per Business Quant data.